United States· US:70954-538_8ab1c887-76fb-44ca-9999-4eefd3778cfc
Tranylcypromine
A tranylcypromine product containing tranylcypromine sulfate, registered in United States by Novitium Pharma LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tranylcypromine is registered in 12 of 19 countries.
Countries holding a registration under ATC N06AF04 (tranylcypromine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Tranylcypromine · ATC N06AF04
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRANYLCYPROMINE SULFATE
- Manufacturer
- Novitium Pharma LLC
- Country
- United States (US)
- ATC code
- N06AF04
- ATC class
- Tranylcypromine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117095453810100 TABLET in 1 BOTTLE (70954-538-10)
- ndc1170954-538-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
197 interactions on record for tranylcypromine.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tranylcypromine · interactions on record
197 records
- 45 severe
- 134 moderate
- 11 minor
- 7 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tranylcypromine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomTranylcypromine 10mg tabletsDE Pharmaceuticals
- NorwayJatrosomAristo Pharma
- CanadaM-TRANYLCYPROMINEMANTRA PHARMA INC
- NetherlandsTracydal 20 mg, filmomhulde tablettenDaleco Pharma b.v.
- SwitzerlandTranylcypromine Rivopharm 10 mg, compressa rivestita con filmRivopharm SA
- SwedenAbbonate 20 mg Filmdragerad tablettAbboxia AB
- GermanyJatrosomAristo Pharma Gmbh (Art 57)
- IrelandParnate 10 mg coated tabletsAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Tranylcypromin Aristo
- Germany · Jatrosom, Tranylcypromin Aristo
- Denmark · Abbonate, Tranylcypromin Holsten
- Spain · Tranilcipromina Aristo
- Finland · Abbonate
- United Kingdom (Northern Ireland) · Parnate, Tranylcypromine
- Ireland · Parnate, Tranylcypromine Eignapharma
- Iceland · Abbonate
- Netherlands · Tracydal, Tranylcypromine Activase
- Norway · Abbonate, Tranylcypromine Afortas
- Sweden · Abbonate, Tranylcypromin Holsten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3949c32-de6d-428b-9ecf-f77600fbaa46 GET /v1/drugs/e3949c32-de6d-428b-9ecf-f77600fbaa46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "TRANYLCYPROMINE SULFATE",
"productndc": "70954-538",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA206856",
"marketing_category": "ANDA"
}See everything about tranylcypromine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.